• 제목/요약/키워드: non-toxicity

검색결과 770건 처리시간 0.023초

Biphenyl 취급사업장의 작업환경 및 유해성 평가 (Working Environment and Risk Assessment of Biphenyl in Workplace)

  • 김현영
    • 한국가스학회지
    • /
    • 제18권2호
    • /
    • pp.55-61
    • /
    • 2014
  • 본 연구는 고무 화학제품의 제조에 연화제로 많이 사용되며 국제암연구소(IARC)에 발암추정물질(2A)로 등록되어 있는 Biphenyl에 대해 국내 취급사업장에 대한 작업환경 측정과 근로자 노출량 산출, 그리고 유해성에 따른 위험성을 결정하였다. 노출시나리오를 바탕으로 노출량 산출 결과는 각각 $1.0{\times}10^{-2}$, $4.2{\times}10^{-4}$, $7.0{\times}10^{-6}mg/m^3$이었으며, 위해성 분류에 따라 산출한 $RfC_{work}$는 발암성 0.21, 표적독성(경구) 2.13, 표적독성(흡입) 0.53, 발달독성 $0.31mg/m^3$으로 산출되었다. 유해성 및 노출평가의 결과를 바탕으로 한 위험성은 발암성 0.57, 비발암성(발달독성) 0.39로 도출되어, 1이하의 비교적 낮은 위험도로 나타났으나, Biphenyl은 일부 유해성이 확인되었으며 사용량이 많고 취급 부주의시 근로자에 직접 노출될 수 있어 취급근로자의 건강장해 예방을 위해 노출 감시가 필요한 물질로 판단되었다.

감국(Chrysanthemum indicum Linne) 에탄올 추출물의 통풍억제 효과 (Anti-Gout Effect of Ethanol Extracts from Chrysanthemum indicum Linne)

  • 박소영;조영제
    • 한국식품영양과학회지
    • /
    • 제45권6호
    • /
    • pp.797-804
    • /
    • 2016
  • 감국 추출물 0.5~10 g/kg을 투여한 급성독성 실험에서는 고용량인 10 g/kg 경구투여에서도 급성독성을 발생시키지 않은 것으로 나타나 안전성이 높은 물질로 확인되었다. 만성독성 실험에서도 최대 2 g/kg까지 13주간 경구 투여하였으나 간 독성이 없는 것으로 나타났다. 감국 추출물을 2~4 g/kg 투여한 그룹에서는 통풍의 염증 및 부종 억제 효과가 있었으나, 10 g/kg 투여군에서는 다소 염증이 증가되는 경향을 나타내었다. 그러므로 통풍억제 효과가 있으나 염증성 사이토카인을 더 증가시키지 않는 4 g/kg의 농도 이하로 감국 추출물을 투여하는 것이 적당한 농도라고 판단되었다. 따라서 감국 추출물은 고용량에서도 비교적 안전한 물질로 monosodium urate crystal에 의한 염증작용을 억제하므로 통풍예방물질로서의 가치가 있다고 생각되었다.

산양산삼복합약침의 표준화 및 급성독성시험 (Component Analysis and Toxicity Study of Combined Cultivated Wild Ginseng Pharmacopuncture)

  • 백상현;이인희;김민정;김은지;하인혁;이진호;이재웅
    • 대한한방내과학회지
    • /
    • 제36권2호
    • /
    • pp.189-199
    • /
    • 2015
  • Objectives: The marker substances of cultivated wild ginseng pharmacopuncture that may not be detected during the process of steaming remain controversial. We developed a combined cultivated wild ginseng pharmacopuncture that contains all the marker substances. The aim of this experiment was to investigate the marker substances and test the toxicity of the combined cultivated wild ginseng pharmacopuncture. Methods: The marker substances were detected using HPLC. Intravenous injection toxicity studies were conducted at Medvill, an authorized institution for non-clinical studies, under the regulations of Good Laboratory Practice. We observed survival rates, abnormal behaviors, weight changes, gross findings in autopsy, blood biochemical properties, and histological abnormalities of organs such as the liver and kidney. Results: HPLC data showed that ginsenosides Rg1, Rb1, and Rg3 were detected at concentrations of 19.29, 47.64, and 3.02 μ g /ml, respectively. Administration of combined cultivated wild ginseng pharmacopuncture resulted in no dead animals or significant toxicological changes. Conclusions: The combined cultivated wild ginseng pharmacopuncture contains all the marker substances and is a relatively safe treatment medium. Further studies should be conducted to confirm the present findings.

Pathogenicity and Single Dose Toxicity of a Potential Probiotic Lactobacillus spp. PSC101 in Mice

  • Hwang, Mi-Hyun;Kim, Young-Hwon;Kim, Eun-Young;Song, Jae-Chan;Lee, Keun-Woo;Jeong, Kyu-Shik;Kim, Kil-Soo;Rhee, Man-hee;Kwon, Oh-Deok
    • Toxicological Research
    • /
    • 제20권2호
    • /
    • pp.173-177
    • /
    • 2004
  • This study was conducted to investigate the pathogenicity and acute single toxicity of Lactobacillus spp. PSC101 (PSC101) isolated from pigs and L. acidophilus (LA) at 2.5$\times$$10^9$CFU or 2.5$\times$$10^{12}$colony forming units (CFU) in mice for 14 days. After oral administration of the bacteria into mice, we could not find their any specific pathogenicity from the standpoints of clinical signs, and changes in body weight and body temperature, as compared with the control group during 14 days. We further investigated the toxicity of concentrated culture broth ($\times$10) after fermentation of them for safe industrial process. As the results, we could not find any clinical signs, changes in body weight and body temperature, as compared with the control group (MRS broth) for 14 days. The results obtained in this study suggest that the potentially probiotic, PSC101, is non-toxic in mice and is therefore likely to be safe for pig use.

Single Oral Dose Toxicity Test of Blue Honeysuckle Concentrate in Mice

  • Kim, Hyung-Soo;Park, Sang-In;Choi, Seung-Hoon;Song, Chang-Hyun;Park, Soo-Jin;Shin, Yong-Kook;Han, Chang-Hyun;Lee, Young Joon;Ku, Sae-Kwang
    • Toxicological Research
    • /
    • 제31권1호
    • /
    • pp.61-68
    • /
    • 2015
  • The objective of this study was to obtain single oral dose toxicity information for concentrated and lyophilized powder of blue honeysuckle (Lonicera caerulea L., Caprifoliaceae; BHcL) in female and male ICR mice to aid in the process of developing natural origin medicinal ingredients or foods following proximate analysis and phytochemical profile measurement. The proximate analysis revealed that BHcL had an energy value of 3.80 kcal/g and contained 0.93 g/g of carbohydrate, 0.41 g/g of sugar, 0.02 g/g of protein, and 0.20 mg/g of sodium. BHcL did not contain lipids, including saturated lipids, trans fats, or cholesterols. Further, BHcL contained 4.54% of betaine, 210.63 mg/g of total phenols, 159.30 mg/g of total flavonoids, and 133.57 mg/g of total anthocyanins. Following administration of a single oral BHcL treatment, there were no treatment-related mortalities, changes in body weight (bw) or organ weight, clinical signs, necropsy or histopathological findings up to 2,000 mg/kg bw, the limited dosage for rodents of both sexes. We concluded that BHcL is a practically non-toxic material in toxicity potency.

편백 정유의 마우스에 대한 급성경구독성 (Acute Oral Toxicity Test of Chamaecyparis obtusa Essential Oil on ICR Mice)

  • 임창우;손송이;이후장
    • 한국식품위생안전성학회지
    • /
    • 제33권3호
    • /
    • pp.214-219
    • /
    • 2018
  • 본 연구는 세균과 진균에 대한 항균작용, 살충작용, 항아토피 활성, 항염증 효과, 혈압강하 및 스트레스 완화 효과 등이 있는 것으로 알려진 편백 정유를 이용하여, 마우스에서의 급성경구독성시험을 수행하였다. 편백 정유를 마우스에 0, 125, 250, 500, 1,000, 2,000 mg/kg body weight의 농도로 각각 1회 경구투여한 결과, 마우스 암 수 모두 2,000 mg/kg에서 모두 생존하였으며, 모든 투여군의 체중 및 모든 혈액학적 혈액생화학적 지표값들이 대조군과 비교하여 통계적으로 유의적인 차이를 보이지 않았다. 따라서 편백 정유의 마우스에서의 $LD_{50}$은 2,000 mg/kg body weight 이상으로 확인되었다.

법제유황의 실용적 제조에 따른 물리 화학적 분석 및 독성, 항균 작용에 관한 연구 (Physiochemical analysis, toxicity test and anti-bacterial effect of practically detoxified sulfur)

  • 인동철;유도현;박철;박진호
    • 한국동물위생학회지
    • /
    • 제35권3호
    • /
    • pp.197-205
    • /
    • 2012
  • Despite of a long history of the sulfur on the disease healing effect, there were limited ways of applying sulfur to animal and human. We have developed the detoxified sulfur (non toxic sulfur) method to make it practical and mass production possible through laboring for many years. This study practiced scanning electron microscope (SEM), Energy dispersive X-ray spectrometer (EDS) and secondary ion mass spectrometry (SIMS) analysis to investigate the physicochemical aspect of detoxified sulfur. We also performed the oral toxicity experiment to mice, and anti-bacterial test of the detoxified sulfur. Based on the SEM, EDS and SIMS results, the united particles in the mass form with the similar component intensity with the raw sulfur were observed, and hydrogen sulfide ion (HS-) component which is regarded as a toxic matter, was decreased after detoxification. Indeed, toxicity test on the mice (10 males, 10 females) showed no clinical, histopathological changes with the 5 times amount (2,500 mg/kg) of the actual doses. However, the male-mice showed decreased in body weight by 23.6%, 24.3% in the 7th, 14th day, respectively, after detoxified sulfur. Moreover, the female-mice administered the detoxified sulfur showed decreased in body weight by 28.7% (P<0.05) than that in the control group on the 14th day. The result of antibacterial test on the detoxified sulfur showed antibacterial effect (27%) to inhibit the growth of Staphylococcus aureus. It is shown that detoxified sulfur can be used as feed additive and has an affect on the farm perfomance.

한국산 겨우살이 Lectin B-chain의 면역증강 효과 (Immunoadjuvant Activity of Korean Mistletoe Lectin B-chain)

  • 허선미;안효선;김규대;김영훈;김인보;윤택준;김종배
    • 생약학회지
    • /
    • 제42권3호
    • /
    • pp.246-252
    • /
    • 2011
  • Korean mistletoe Lectin (KML-C) is composed of A and B sub-chain. B chain binds to carbohydrates on cell surface and A chain hinders translation and induces an apoptosis as a RIP (ribosome inactivating protein). KML-C has very strong biological activities, it has seriously limits to use as a cancer therapy or adjuvant because of its toxicity to normal cells. This study is therefore conducted to see if B chain of KML-C might have immunological activity, especially adjuvant activities with less toxicity. We isolated B chain from KML-C using the lactose affinity chromatography, and examined their immunoadjuvant activity. The isolated B-chain did not show any cytotoxicity against tumor cell, RAW264.7, and P388D1 while KML-C had a very strong toxicity. This non-toxic effect was observed also by in-vivo study. Both humoral and cellular immunities were observed ; the antibody titer was increased when the mice were immunized with B-chain used as adjuvant like Freund's adjuvant, indicating that B chain of mistletoe lectin alone might be used for adjuvant; it also increased DTH in cellular immunity. These results suggest that B-chain of KML-C might be used for adjuvant used for the production of antibody or vaccine with less toxicity.

Lipid emulsion therapy of local anesthetic systemic toxicity due to dental anesthesia

  • Rhee, Seung-Hyun;Park, Sang-Hun;Ryoo, Seung-Hwa;Karm, Myong-Hwan
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • 제19권4호
    • /
    • pp.181-189
    • /
    • 2019
  • Local anesthetic systemic toxicity (LAST) refers to the complication affecting the central nervous system (CNS) and cardiovascular system (CVS) due to the overdose of local anesthesia. Its reported prevalence is 0.27/1000, and the representative symptoms range from dizziness to unconsciousness in the CNS and from arrhythmias to cardiac arrest in the CVS. Predisposing factors of LAST include extremes of age, pregnancy, renal disease, cardiac disease, hepatic dysfunction, and drug-associated factors. To prevent the LAST, it is necessary to recognize the risk factors for each patient, choose a safe drug and dose of local anesthesia, use vasoconstrictor, confirm aspiration and use incremental injection techniques. According to the treatment guidelines for LAST, immediate application of lipid emulsion plays an important role. Although lipid emulsion is commonly used for parenteral nutrition, it has recently been widely used as a non-specific antidote for various types of drug toxicity, such as LAST treatment. According to the recently published guidelines, 20% lipid emulsion is to be intravenously injected at 1.5 mL/kg. After bolus injection, 15 mL/kg/h of lipid emulsion is to be continuously injected for LAST. However, caution must be observed for >1000 mL of injection, which is the maximum dose. We reviewed the incidence, mechanism, prevention, and treatment guidelines, and a serious complication of LAST occurring due to dental anesthesia. Furthermore, we introduced lipid emulsion that has recently been in the spotlight as the therapeutic strategy for LAST.

Wheat phytase can alleviate the cellular toxic and inflammatory effects of lipopolysaccharide

  • An, Jeongmin;Cho, Jaiesoon
    • Journal of Animal Science and Technology
    • /
    • 제63권1호
    • /
    • pp.114-124
    • /
    • 2021
  • The objective of this study was to characterize the enzymatic hydrolysis of lipopolysaccharide (LPS) by wheat phytase and to investigate the effects of wheat phytase-treated LPS on in vitro toxicity, cell viability and release of a pro-inflammatory cytokine, interleukin (IL)-8 by target cells compared with the intact LPS. The phosphatase activity of wheat phytase towards LPS was investigated in the presence or absence of inhibitors such as L-phenylalanine and L-homoarginine. In vitro toxicity of LPS hydrolyzed with wheat phytase in comparison to intact LPS was assessed. Cell viability in human aortic endothelial (HAE) cells exposed to LPS treated with wheat phytase in comparison to intact LPS was measured. The release of IL-8 in human intestinal epithelial cell line, HT-29 cells applied to LPS treated with wheat phytase in comparison to intact LPS was assayed. Wheat phytase hydrolyzed LPS, resulting in a significant release of inorganic phosphate for 1 h (p < 0.05). Furthermore, the degradation of LPS by wheat phytase was nearly unaffected by the addition of L-phenylalanine, the inhibitor of tissue-specific alkaline phosphatase or L-homoarginine, the inhibitor of tissue-non-specific alkaline phosphatase. Wheat phytase effectively reduced the in vitro toxicity of LPS, resulting in a retention of 63% and 54% of its initial toxicity after 1-3 h of the enzyme reaction, respectively (p < 0.05). Intact LPS decreased the cell viability of HAE cells. However, LPS dephosphorylated by wheat phytase counteracted the inhibitory effect on cell viability. LPS treated with wheat phytase decreased IL-8 secretion from intestinal epithelial cell line, HT-29 cell to 14% (p < 0.05) when compared with intact LPS. In conclusion, wheat phytase is a potential therapeutic candidate and prophylactic agent for control of infections induced by pathogenic Gram-negative bacteria and associated LPS-mediated inflammatory diseases in animal husbandry.